METHODS An electronic search was conducted from June 2024 to July 2024, with an updated search in August 2024, using databases PubMed, PubMed Central, Clinicaltrials.gov, Ovid Medline, and CINAHL
Some of the GLP-1 agonists drugs in the pipeline include orforglipron by Eli Lilly and company , survodutide by Boehringer Ingelheim, danuglipron by Pfizer , and retatrutide by Eli Lilly and company , among others
This article belongs to the PlexusDx Education Hub, where we unpack GLP-1 therapies, weight-management protocols, and the genetic variables behind every metabolic decision
Following a 20-week run-in phase, participants achieved a mean weight reduction of 10.6% before randomization
Med ., 11 , 784
Final Thoughts GLP-1 drugs are changing the landscape of obesity and diabetes treatment